Tox21_300575

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 11 USDMF, 2 CEP/COS, 1 EU WC, 2 NDC API, 5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers, 29 FDA Orange Book, 25 Europe, 18 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML, CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Evonik, 1 Rochem International Inc, 1 SPI Pharma, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 13 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

57 Coating Systems & Additives, 31 Controlled & Modified Release, 24 Disintegrants & Superdisintegrants, 21 Thickeners and Stabilizers, 20 Fillers, Diluents & Binders, 14 Granulation, 14 Solubilizers, 13 Film Formers & Plasticizers, 12 Taste Masking, 12 Topical, 11 Direct Compression, 9 Empty Capsules, 7 Lubricants & Glidants, 7 Co-Processed Excipients, 5 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Emulsifying Agents, 2 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Parenteral

GLOBAL SALES INFORMATION

8 Regulatory FDF Prices

8 Regulatory FDF Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 4 Others

Xls

Filters

Tox21_300575

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

BePharma

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

BePharma

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Tox21_300575? Find Coloring Agents used in Tox21_300575 to address drug delivery challenges on PharmaCompass.

Tox21_300575

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

11 USDMF

2 CEP/COS

1 EU WC

2 NDC API

5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers

29 FDA Orange Book

25 Europe

18 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

5 Evonik

1 Rochem International Inc

1 SPI Pharma

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

3 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

18 BASF

13 Corel Pharma Chem

4 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

8 Ideal Cures

2 Ingredion Pharma Solutions

10 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

6 Microlex e.U

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

12 Roquette

7 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

2 Valens Pharmachem

3 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

57 Coating Systems & Additives

31 Controlled & Modified Release

24 Disintegrants & Superdisintegrants

21 Thickeners and Stabilizers

20 Fillers, Diluents & Binders

14 Granulation

14 Solubilizers

13 Film Formers & Plasticizers

12 Taste Masking

12 Topical

11 Direct Compression

9 Empty Capsules

CAPSULE, DELAYED REL PELLETS;ORAL - 125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons